A detailed history of Peak Asset Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Peak Asset Management, LLC holds 383 shares of LLY stock, worth $302,309. This represents 0.07% of its overall portfolio holdings.

Number of Shares
383
Previous 383 -0.0%
Holding current value
$302,309
Previous $346,000 2.02%
% of portfolio
0.07%
Previous 0.07%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$592.2 - $792.28 $36,124 - $48,329
-61 Reduced 13.74%
383 $297,000
Q4 2023

Feb 12, 2024

BUY
$525.19 - $619.13 $15,230 - $17,954
29 Added 6.99%
444 $258,000
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $180,400 - $248,709
415 New
415 $222,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $750B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Peak Asset Management, LLC Portfolio

Follow Peak Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak Asset Management, LLC with notifications on news.